US HB7653 | 2021-2022 | 117th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on May 3 2022 - 25% progression, died in committee
Action: 2022-05-03 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 3 2022 - 25% progression, died in committee
Action: 2022-05-03 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to modernize the methods of authenticating controlled substances in the pharmaceutical distribution supply chain, and for other purposes.
Title
Modern Authentication of Pharmaceuticals Act of 2022
Sponsors
| Sen. Markwayne Mullin [R-OK] | Rep. Tom O'Halleran [D-AZ] |
History
| Date | Chamber | Action |
|---|---|---|
| 2022-05-03 | House | Referred to the House Committee on Energy and Commerce. |
| 2022-05-03 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/7653/all-info |
| Text | https://www.congress.gov/117/bills/hr7653/BILLS-117hr7653ih.pdf |
